BIIB

Biogen Inc.

Healthcare›Drug Manufacturers - General|NASDAQ Global Select|US

Price

$177.34

Market Cap

$26.03B

Beta

0.16

P/E

19.9

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+1.39%

EPS Growth (YoY)-21.09%

Revenue CAGR 3Y-1.20%

P/E Ratio19.9

PEG Ratio—

FCF Yield+8.22%

Debt / Equity0.38

Interest Coverage7.0x

No credit card required

Already have an account? Sign in to view the full analysis for BIIB.